A: Trust in our health system is influenced by our beliefs about its benefits and consequences to ourselves and others. Low trust can derail the best of public health and medical treatments. Trust in the US health system is complicated by experiences and historical events that non-majority communities. People need time, reliable information, and repeated …
A: This is an evolving situation. Actions today could result in great success or tragic loss. Key take aways— B.1.1.7 is in the US. Growing evidence suggests the B.1.1.7 variant spreads more easily than previous variants. New evidence supports the hypothesis that current vaccines are effective against B.1.1.7. Early efforts to contain B.1.1.7 buys time …
In this live Q&A, Drs. Malia Jones & Ashley Ritter will be tackling pandemic questions from our readers. Today’s we’re answering questions from readers about whether you should get the vaccine if you’ve already had COVID and much more! ➡️ Welcome and NG Ashley gets her vax! (0:00-3:07) ➡️ Vaccination info for those who have …
R: Siendo realistas, no. Biológicamente, las posibilidades de efectos a largo plazo son extremadamente pequeños. BREVE RESUMEN: Los efectos secundarios graves de la vacuna son extremadamente raros y ocurren horas o días después de la vacunación, no meses o años.* El riesgo de infección y los efectos a largo plazo en la salud a causa …
Q: Is this a worry with the vaccine? What about with reinfection?” A: Antibody-dependent enhancement or ADE is not a concern with the Pfizer and Moderna vaccines and will not likely be a concern with the other vaccines that will be approved. Vaccine developers and the FDA are all looking carefully for any evidence of …
Q: Why can’t we get available vaccine doses administered more quickly? A: Many factors: The holidays, lack of funding, staffing and logistical challenges, getting large-scale vaccine operations up and running, sticking to prioritization schemes, and lower take-up among high-priority groups. Things should be speeding up in the next few weeks. It’s frustrating to see statistics …
In this live Q&A, Drs. Malia Jones & Amanda Simanek will be tackling pandemic questions from our readers. We’ll take questions about the “mutant strain”, which vaccine is best, that rumor about asymptomatic transmission being a phantom, and what we know (and don’t) about whether someone can still spread COVID after being vaccinated. ➡️ Welcome …
A: The Oxford/Astrazeneca vaccine was granted emergency authorization & the British government has decided to give as many people a first vaccine dose while delaying second doses *up to* 12 weeks after the first. A big news week here in the UK where this Nerdy Girl (Jenn) lives. Besides the worldwide focus on the new …
A: About 70-90% of the population will need to get the COVID-19 vaccine to stop transmission. If vaccine acceptance is low, it could take until late 2022 to reach herd immunity. If vaccine acceptance is high, we could be well on our way by this summer. The good news: people are reporting less hesitancy and …
R: El próximo grupo que se vacunará en EE.UU., con el pegajoso título de “Fase 1b”, incluirá a personas de 75 años o más, además de trabajadores esenciales de primera línea. Eso incluye: 👩🏫 Maestros, personal de apoyo educativo y trabajadores de guarderías; 👩🚒 Bomberos y policía; 👩🌾 Trabajadores de la agricultura y la alimentación; …